CRPHAGE Trademark

Trademark Overview


On Monday, December 13, 2021, a trademark application was filed for CRPHAGE with the United States Patent and Trademark Office. The USPTO has given the CRPHAGE trademark a serial number of 97169063. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 8, 2024. This trademark is owned by Locus Biosciences, Inc.. The CRPHAGE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for targeting and destroying bacteria; pharmaceutical preparations for the treatment of antibiotic-resistant bacterial infections and microbiome-related disorders; pharmaceutical preparations for use in the field of engineered bacteriophage; pharmaceuticals designed to deliver highly targeted therapeutic modulation for patients suffering from a variety of diseases, namely, cancer, autoimmune and inflammatory diseases namely, transplantation and delayed-type hypersensitivity, respiratory diseases, gastrointestinal diseases, cardiovascular and metabolic diseases, pathogen infections, musculoskeletal diseases, ophthalmologic and dermatologic diseases, genitourinary diseases, degenerative diseases, and orphan diseases
crphage

General Information


Serial Number97169063
Word MarkCRPHAGE
Filing DateMonday, December 13, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 8, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 11, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations for targeting and destroying bacteria; pharmaceutical preparations for the treatment of antibiotic-resistant bacterial infections and microbiome-related disorders; pharmaceutical preparations for use in the field of engineered bacteriophage; pharmaceuticals designed to deliver highly targeted therapeutic modulation for patients suffering from a variety of diseases, namely, cancer, autoimmune and inflammatory diseases namely, transplantation and delayed-type hypersensitivity, respiratory diseases, gastrointestinal diseases, cardiovascular and metabolic diseases, pathogen infections, musculoskeletal diseases, ophthalmologic and dermatologic diseases, genitourinary diseases, degenerative diseases, and orphan diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 7, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLocus Biosciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMorrisville, NC 27560

Party NameLocus Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMorrisville, NC 27560

Trademark Events


Event DateEvent Description
Monday, January 8, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 8, 2024ABANDONMENT - NO USE STATEMENT FILED
Tuesday, June 6, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 11, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 11, 2023PUBLISHED FOR OPPOSITION
Wednesday, March 22, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 7, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 7, 2023EXAMINER'S AMENDMENT ENTERED
Tuesday, March 7, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, March 7, 2023EXAMINERS AMENDMENT E-MAILED
Tuesday, March 7, 2023EXAMINERS AMENDMENT -WRITTEN
Wednesday, September 21, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 21, 2022NON-FINAL ACTION E-MAILED
Wednesday, September 21, 2022NON-FINAL ACTION WRITTEN
Tuesday, September 20, 2022ASSIGNED TO EXAMINER
Thursday, December 16, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 16, 2021NEW APPLICATION ENTERED